Literature DB >> 856011

Penetration of cefazolin, cephaloridine, and cefamandole into interstitial fluid in rabbits.

C Carbon, A Contrepois, N Brion, S Lamotte-Barrillon.   

Abstract

We compared the penetration of three cephalosporins into interstitial fluid. Interstitial fluid was obtained in rabbits from Silastic tissue cages. Cefazolin, cephaloridine, and cefamandole were administered by the intramuscular route (30 mg/kg per injection). Peak blood levels and interstitial concentrations were studied after a single injection. Interstitial levels were also compared in a three-injection study (one injection every 12 h) and in a cumulative effect study (six injections), in which the interval between injections was established for each drug on the basis of its common therapeutic use. After a single injection, cephaloridine activity was detected more rapidly and attained higher levels than the other two drugs within the first 4 h. However, 2 h after the third injection, cefazolin levels in tissue fluid were higher than with cephaloridine. Cefamandole consistently gave the lowest interstitial levels. With all three drugs, detectable concentrations were present in interstitial fluid at a time when no detectable antibiotic was found in serum. In the six-injection study, the interstitial levels obtained with cefazolin were significantly higher than those observed with the other drugs. Our data suggest that cefazolin is a drug of choice due to its high extravascular levels.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856011      PMCID: PMC352034          DOI: 10.1128/AAC.11.4.594

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Cefazolin, a new semisynthetic cephalosporin antibiotic. II. In vitro and in vivo antimicrobial activity.

Authors:  M Nishida; T Matsubara; T Murakawa; Y Mine; Y Yokota
Journal:  J Antibiot (Tokyo)       Date:  1970-03       Impact factor: 2.649

2.  Cefazolin vs cephalothin and cephaloridine. A comparison of their clinical pharmacology.

Authors:  C Regamey; R C Gordon; W M Kirby
Journal:  Arch Intern Med       Date:  1974-03

3.  Penetration of antibiotics into fibrin loci in vivo. I. Comparison of penetration of ampicillin into fibrin clots, abscesses, and "interstitial fluid".

Authors:  M Barza; L Weinstein
Journal:  J Infect Dis       Date:  1974-01       Impact factor: 5.226

4.  Penetration of antibiotics into fibrin loci in vivo. II. Comparison of nine antibiotics: effect of dose and degree of protein binding.

Authors:  M Barza; T Samuelson; L Weinstein
Journal:  J Infect Dis       Date:  1974-01       Impact factor: 5.226

5.  Concentration of antibacterial agents in interstitial tissue fluid.

Authors:  G D Chisholm; P M Waterworth; J S Calnan; L P Garrod
Journal:  Br Med J       Date:  1973-03-10

6.  Pathophysiology of tissue fluid.

Authors:  J S Calnan; J J Pflug; G D Chisholm; L M Taylor
Journal:  Proc R Soc Med       Date:  1972-08

7.  Interstitial fluid and serum antibiotic concentrations.

Authors:  N G Waterman; L B Kastan
Journal:  Arch Surg       Date:  1972-08

8.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

9.  A rapid, modified ultrafiltration method for determining serum protein binding and its application to new penicillins.

Authors:  J V Bennett; W M Kirby
Journal:  J Lab Clin Med       Date:  1965-11

10.  Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

View more
  23 in total

1.  Effect of protein binding in serum on therapeutic efficacy of cephem antibiotics.

Authors:  S Tawara; S Matsumoto; T Kamimura; S Goto
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

Review 2.  Protein binding of antimicrobials: clinical pharmacokinetic and therapeutic implications.

Authors:  W A Craig; P G Welling
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

3.  Penetration of cefpiramide and cefazolin into peritoneal capsular fluid in rabbits.

Authors:  H Matsui; T Okuda
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

4.  Effect of protein binding on drug penetration into blister fluid.

Authors:  W C Shyu; R Quintiliani; C H Nightingale; M N Dudley
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

5.  Distribution of penicillin G in serum and tissue cage fluid in cattle.

Authors:  J Luthman; S O Jacobsson
Journal:  Acta Vet Scand       Date:  1986       Impact factor: 1.695

6.  Comparative pharmacokinetics of ceftazidime in fibrin clots and cardiac vegetations in rabbits with Staphylococcus aureus endocarditis.

Authors:  A A McColm; D M Ryan
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

7.  Canine model for the simultaneous measurement of antibiotic levels in tissues and bacterial killing rate.

Authors:  D S Wagner; S J Salstrom; T M File; J S Tan
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

8.  Role of serum protein binding and multiple antibiotic doses in the extravascular distribution of ceftizoxime and cefotaxime.

Authors:  D N Gerding; L L Van Etta; L R Peterson
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

9.  Comparison study of the kinetics of ceftizoxime penetration into extravascular spaces with known surface area/volume ratio in vitro and in vivo in rabbits.

Authors:  L L Van Etta; C E Fasching; L R Peterson; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

10.  Ascitic fluid cephalosporin concentrations: influence of protein binding and serum pharmacokinetics.

Authors:  D N Gerding; L R Peterson; D C Legler; W H Hall; E A Schierl
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.